Pasithea Therapeutics Corp (KTTA): O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Pasithea Therapeutics (KTTA) uchun xavflar takrorlanuvchi daromadning yo'kligi va psixiatrik ishlanmalarning potensial muvaffaqiyatsizligi bilan bog'liq. P/E koeffitsiyentining o'sish tendentsiyasi barqarorlik ko'rsatkichi bo'lib xizmat qiladi, bunda 0.00 ushbu parametr darajasini belgilaydi. Ketamin markazlaridagi bemorlarning yuqori sadoqati va DEA ning qat'iy nazorati barqarorlikni ta'minlaydi, aktivlar qiymati esa mijozlar oqimi va PTSD terapiyasi borasidagi muvaffaqiyatlarga asoslanadi.
Pasithea Therapeutics (KTTA) kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- kompaniyaning balans qiymati tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Pasithea Therapeutics|KTTA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati pasitheaclinics.com|KTTA - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Pasithea|KTTA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Pasithea Therapeutics|Oraliq likvidlik koeffitsiyenti pasitheaclinics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
KTTA - Sof foyda|Kutilayotgan sof daromad Pasithea Therapeutics|KTTA - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati pasitheaclinics.com|KTTA - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Pasithea|KTTA - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Pasithea Therapeutics|KTTA - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi pasitheaclinics.com|KTTA - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Pasithea Therapeutics
Kompaniyaning umumiy tahlili:KTTA Pasithea Therapeutics Corp
Pasithea Therapeutics (KTTA) bozor qiymati miya buzilishlari terapiyasi uchun klinik sinovlarning muvaffaqiyati va R&D moliyalashtirish hajmi bilan bevosita bog'liq. PEG koeffitsiyentini tahlil qilish orqali investor joriy P/E koeffitsiyentini foyda o'sish sur'ati bilan solishtiradi: birdan past qiymat aktivning kengayishiga nisbatan past baholanganligini anglatadi va ushbu biotexnologiya kompaniyasining biznes modelining barqarorligini tasdiqlaydi.
Pasithea Therapeutics kimlar bilan raqobatlashadi
PEG multiplikatori Biogen Inc (BIIB)|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Regencell Corp (RGC)|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acadia-pharm.com ACAD|XENE (Xenon) - Narx-foyda va o‘sish multiplikatori|VKTX: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|SUPN (Supernus Pharma) - PEG multiplikatori|CPRX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori DNLI|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori BHVN (Biohaven)|PEG multiplikatori Amylyx Pharmaceuticals Inc AMLX|TRVI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Corp)|AVXL (Anavex Life Sciences) - Narx-foyda va o‘sish multiplikatori|CBLL: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PRTA (Prothena Corporation plc) - PEG multiplikatori|ALEC: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANNX|OMER - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Neurogene Inc. NGNE|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|NMRA - PEG multiplikatori|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati TVGN (Tevogen Bio Inc.)|ACOG (Alpha Cognition Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda cogrx.com CGTX|Narx-foyda va o‘sish multiplikatori IKT (Inhibikase Therapeutics, Inc.)|PEG multiplikatori Cassava Sciences Inc (SAVA)|Assertio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati COYA (Coya Therapeutics Inc)|VistaGen Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ovid Therapeutics Inc. OVID|ABOS: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori CervoMed, Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Ltd.|Clene Nanomedicine (CLNN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|PEG multiplikatori jupiterneurosciences.com (JUNS)|Relmada Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ANVS (Annovis Bio Inc)|GRCE: Narx-foyda va o‘sish multiplikatori|Firefly Neuro - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|KLTO: PEG multiplikatori|NeuroSense Therapeutics Ltd. (NRSN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti MTVA (MetaVia, Inc.)|PEG multiplikatori NRXS|HSDT - O‘sish sur’atiga tuzatilgan narx-foyda|Passage Bio - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Neuphoria Therapeutics, Inc. NEUP|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ATHA (Athira Pharma Inc)|Addex Therapeutics, Ltd. (ADXN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Alzamend Neuro (ALZN)|Narxning foydaga va o‘sish sur’atiga nisbati Cyclerion Therapeutics Inc.|Protagenic - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori CRGT|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Cara Therapeutics Inc (CARA)|Chromocell Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Eliem Therapeutics ELYM|ITCI (intracellulartherapies.com) - Narx-foyda va o‘sish multiplikatori|LBPH: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|MRNS (Marinus) - PEG multiplikatori|NKGN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NRBO|SAGE - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori SNPX (Synaptogenix)|PEG multiplikatori Trevena Inc. TRVN|VIGL: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical Inc.)|CERE (Cerevel Therapeutics) - Narx-foyda va o‘sish multiplikatori
